Author

P. Merida

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Biophysics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 6 Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

D. Muriaux· 6 shared C. Favard· 3 shared S. Lyonnais· 3 shared A. Neyret· 2 shared C. Chable-Bessia· 2 shared D. Bracquemond· 2 shared J. M. Swain· 2 shared J. Mak· 2 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersMicrobiology

D. Muriaux

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Optimized production and fluorescent labelling of SARS-CoV-2 Virus-Like-Particles to study virus assembly and entry.

D. Muriaux, M. Gourdelier, J. M. Swain, C. Arone, A. Mouttou, D. Bracquemond, P. Merida, S. Saffarian, S. Lyonnais, C. Favard

This paper optimizes the production of SARS-CoV-2 Virus-Like Particles (VLPs) and demonstrates their fluorescent labeling for studying virus assembly and entry mechanisms.

bioRxiv · Mar 23, 2022 · PreprintMicrobiology

Reorganization of F-actin nanostructures is required for the late phases of SARS-CoV-2 replication in pulmonary cells.

J. Swain, P. Merida, K. Rubio, D. Bracquemond, I. Aguilar-Ordonez, S. Guenther, G. Barreto, D. Muriaux

This study shows that reorganization of F-actin nanostructures is critical for late stages of SARS-CoV-2 replication in pulmonary cells, with alpha-actinins playing a key role.

bioRxiv · Mar 8, 2022 · PreprintMicrobiology

Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.

C. Chable-Bessia, C. Boulle, A. Neyret, J. M. Swain, M. Henaut, P. Merida, N. Gros, A. Makinson, S. Lyonnais, C. B. Chesnais, D. Muriaux

This study evaluates the anti-SARS-CoV-2 activity of ivermectin and other macrocyclic lactones in vitro, finding low selectivity indices that suggest limited therapeutic potential for COVID-19.

bioRxiv · Nov 1, 2021 · PreprintMicrobiology

Full assembly of HIV-1 particles requires assistance of the membrane curvature factor IRSp53.

K. Inamdar, F.-C. Tsai, A. dePoret, R. Dibsy, J. Manzi, P. Merida, R. Muller, P. Lappalainen, P. Roingeard, J. Mak, P. Bassereau, C. Favard, D. MURIAUX

This study shows that IRSp53 assists HIV-1 in forming membrane curvature necessary for complete particle assembly.

bioRxiv · Feb 10, 2021Biophysics

Direct visualization of native infectious SARS-CoV-2 and its inactivation forms using high resolution Atomic Force Microscopy

S. Lyonnais, M. Henaut, A. Neyret, P. Merida, N. Gros, C. Chable-Bessia, D. Muriaux

This paper uses atomic force microscopy to visualize native and inactivated SARS-CoV-2 viruses, showing their structural changes after formaldehyde treatment.

bioRxiv · Oct 23, 2020 · PreprintMicrobiology

HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly.

C. Favard, J. Chojnacki, P. Merida, N. Yandrapalli, J. Mak, C. Eggeling, D. Muriaux

bioRxiv · Feb 21, 2019Biophysics